Expert Advice When You Need It Most

William W Vodra

10.0

Superb

10

Experience 5.0 star rating
Industry Recognition 4.0 star rating
Professional Conduct 5.0 star rating

What is the Avvo Rating?

Client Reviews

Not yet reviewed
No professional misconduct found.

Overview

Practice Areas

Chart?chs=124x124&cht=p&chp=4
  • 40% Life Sciences / Biotechnology
  • 20% Criminal Defense
  • 20% Government
  • 20% Health Care

Contact Information

  • Arnold & Porter LLP
    555 Twelfth Street, NW
    Washington, DC 20004
    Office: 202-942-5088
    Fax: 202-942-5999
    View map | Edit this address

References

Client Reviews

How would you rate this lawyer?

If you're a current or former client, share your thoughts (anonymously, if you prefer). Would you recommend this lawyer to other clients?

Review this lawyer

Peer Endorsements

Endorse a fellow lawyer, get more visits to your profile

In addition to providing a simple way to express your gratitude to fellow lawyers, any time you add an endorsement to a peer's profile, a link to your profile will appear on it.

Endorse this lawyer

Résumé

 

License

30 years since William W Vodra was first licensed to practice law.

State License status Year acquired Last updated by Avvo
Dist. of Columbia Active 1981 10/03/2009

We have not found any instances of professional misconduct for this lawyer.

Education

School Major Degree Graduated
Columbia University School of Law Law JD - Juris Doctor 1968
College of Wooster BA - Bachelor of Arts 1965

Awards

Award Name Granting Organization Date
Best Lawyers in America 2007
Leading Lawyer in Food and Drug Law 2005
See all 3 awards

Portfolio

Publications

Article Publication Date
Medical Technology Multinationals and the US - Navigating the Regulatory Framework Practical Law Company's Cross-Border Life Sciences Handbook 2007
The Food and Drug Administration's Evolving Regulation of Press Releases: Limits and Challenges Food and Drug Law Journal 2006
See all 11 publications

Speaking Engagements

Presentation Name Conference Date
Anticipating the FDA Regulatory Environment for Product Review Unknown